DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

EXACT Sciences Corp (NASDAQ: EXAS)

22.49 1.16 (5.44%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

EXAS $22.49 5.44%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $21.34
Previous Close $21.33
Daily Range $21.33 - $22.62
52-Week Range $10.69 - $29.97
Market Cap $2.0B
P/E Ratio -17.06
Dividend (Yield) $0.00 (0.0%)
Volume 1,930,599
Average Daily Volume 2,176,633
Current FY EPS -$1.57




Drug Makers

EXACT Sciences Corp (EXAS) Description

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer. Website:

News & Commentary Rss Feed

Why Exact Sciences Corporation Is Dropping Today

Exact Sciences shares were cut to neutral today by Goldman Sachs.

Exact (EXAS) Showing Signs Of A Dead Cat Bounce Today

Goldman Sachs Cuts Myriad Genetics To Sell, Ups Alere

Notable Two Hundred Day Moving Average Cross - EXAS

Exact Sciences Had Wildly Successful 2014, Can We Expect The Same In 2015?

Why It's Not Too Late to Buy Exact Sciences Corporation

Exact Sciences has more than quadrupled the return of the S&P 500 over the trailing-two-year period, but these five points suggest its run higher could just be starting.

Exact Sciences Grants Inducement Restricted Stock Unit Awards to New Employees

Ironwood, Exact Sciences Ink Cologuard Co-Promotion Deal - Analyst Blog

Ironwood, Exact Sciences Ink Cologuard Co-Promotion Deal - Analyst Blog

Exact (EXAS) Highlighted As Today's Perilous Reversal Stock

Why Exact Sciences Corporation Is Soaring Higher

Exact Sciences shares are jumping after Aetna agrees to cover its Medicare Advantage members.

See More EXAS News...

EXAS's Top Competitors

EXAS $22.49 (5.44%)
Current stock: EXAS
AMGN $162.59 (1.27%)
Current stock: AMGN
GILD $101.00 (-0.07%)
Current stock: GILD
BIIB $429.87 (0.22%)
Current stock: BIIB